Prof. Dai Wenyan is a senior oncology specialist with more than 20 years of experience in minimally invasive cancer treatment and personalized oncology care. She is widely recognized for her expertise in breast cancer management, particularly in combining advanced medical technology with patient-centered treatment approaches.
Her clinical focus includes minimally invasive therapies, targeted treatment strategies, and immunotherapy evaluation for various types of cancer.
Areas of Expertise
Minimally Invasive Cancer Treatment
Prof. Dai specializes in advanced minimally invasive procedures, including:
- Cryoablation therapy
- Radioactive seed implantation
- Image-guided precision treatment
These techniques are designed to reduce surgical trauma while improving treatment precision and recovery outcomes.
Personalized Oncology & Immunotherapy
She is experienced in:
- Personalized treatment planning
- Targeted therapy strategies
- Immunotherapy efficacy evaluation
Her approach emphasizes evidence-based treatment tailored to each patient’s condition.
Cancer Specialties
Prof. Dai has extensive experience treating:
- Breast cancer
- Lung cancer
- Gastrointestinal cancers
- Gynecological tumors
Career & Leadership
Clinical Experience
With over two decades of oncology experience, Prof. Dai has played an important role in advancing minimally invasive cancer therapies in China.
International Training
She completed advanced clinical training and fellowships at:
- Sun Yat-sen Memorial Hospital
- National University of Singapore Cancer Institute
Professional Appointments
Prof. Dai currently serves as:
- Vice Chair of the GCOG China County Clinical Research Committee (2024–2027)
- Standing Committee Member of the Expert Panel on Personalized Treatment under the Chinese Anti-Cancer Association
- Executive Member of the Particle Therapy Committee under the Chinese Anti-Cancer Association
Achievements at Modern Cancer Hospital Guangzhou
Breast Cancer Center Development
Since leading the breast cancer team in 2016, Prof. Dai and her team have managed more than 20,000 breast cancer cases.
High Breast-Conservation Rate
Under her leadership, the center has achieved a breast-conservation rate of approximately 50–60%, placing it among the leading standards in the field.
Innovative Triple-Therapy Protocol
Prof. Dai pioneered a comprehensive treatment model that integrates:
- Breast-conserving surgery
- Minimally invasive procedures such as cryoablation
- Breast reconstruction and repair
This approach aims to maximize treatment effectiveness while preserving both physical appearance and quality of life.
Academic & Research Contributions
Clinical Guidelines & Standardization
Prof. Dai is actively collaborating with leading medical institutions, including Sun Yat-sen University Cancer Center, to develop consensus guidelines and standardized protocols for breast cancer treatment.
Research & Conferences
In 2024, she presented research at the Chinese Congress on Holistic Integrative Oncology on the topic:
“Frontier Explorations in Immunotherapy Efficacy Evaluation Systems.”
Treatment Philosophy
Prof. Dai Wenyan believes that effective cancer treatment should combine advanced medical technology with compassionate patient care. Her philosophy focuses on delivering scientifically proven, personalized, and humane oncology treatment that supports both physical recovery and emotional well-being.
